MSB went from 20c to > $10 bucks on no revenue & great expectations. Plenty of upside to the sp here with all that mentioned by @mightypirate & maybe not all that far away imo.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential